China NMPA Drug Inspection - Gansu Minhai Pharmaceutical Co., Ltd. - Anti-inflammatory and antipyretic granules
China NMPA drug inspection for Gansu Minhai Pharmaceutical Co., Ltd. published July 31, 2013. Drug: Anti-inflammatory and antipyretic granules. The Henan Provincial Food and Drug Administration, operating under the NMPA framework, announced the results of comprehe
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Minhai Pharmaceutical Co., Ltd. published July 31, 2013. Drug: Anti-inflammatory and antipyretic granules. The Henan Provincial Food and Drug Administration, operating under the NMPA framework, announced the results of comprehe
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox